Fensolvi 45 mg/.375mL
Leuprolide Acetate · INJECTION, SUSPENSION, EXTENDED RELEASE · TOLMAR Inc.
No Recall History
Plain English
Fensolvi is a injection, suspension, extended release containing leuprolide acetate at 45 mg/.375mL, taken subcutaneous. Manufactured by TOLMAR Inc..
Key Facts
- Brand Name
- Fensolvi
- Generic Name
- Leuprolide Acetate
- NDC Code (Product)
62935-163- Manufacturer
- TOLMAR Inc.
- Strength
- 45 mg/.375mL
- Dosage Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA213150
- Marketing Start
- 03/06/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Fensolvi used for?
Fensolvi contains Leuprolide Acetate. It is a injection, suspension, extended release taken subcutaneous. Consult your doctor for specific uses.
Is Fensolvi a controlled substance?
Fensolvi is not classified as a controlled substance by the DEA.
What is the generic name for Fensolvi?
The generic name for Fensolvi is Leuprolide Acetate. There are 12 other brand versions of Leuprolide Acetate.
What is the NDC code for Fensolvi 45 mg/.375mL?
The NDC (National Drug Code) for Fensolvi 45 mg/.375mL is 62935-163, listed by TOLMAR Inc..